CN104961749A - 一种头孢呋辛钠的新型工业结晶技术 - Google Patents
一种头孢呋辛钠的新型工业结晶技术 Download PDFInfo
- Publication number
- CN104961749A CN104961749A CN201510330842.8A CN201510330842A CN104961749A CN 104961749 A CN104961749 A CN 104961749A CN 201510330842 A CN201510330842 A CN 201510330842A CN 104961749 A CN104961749 A CN 104961749A
- Authority
- CN
- China
- Prior art keywords
- cefuroxime sodium
- sodium
- crystallization
- cefuroxime
- infant industry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
- B01D9/0054—Use of anti-solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D2009/0086—Processes or apparatus therefor
- B01D2009/009—Separation of organic compounds by selective or extractive crystallisation with the aid of auxiliary substances forming complex or molecular compounds, e.g. with ureum, thioureum or metal salts
- B01D2009/0095—Separation of organic compounds by selective or extractive crystallisation with the aid of auxiliary substances forming complex or molecular compounds, e.g. with ureum, thioureum or metal salts with the aid of other complex forming substances than ureum, thioureum or metal salts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
检测项 | 高度H | 半径r | 休止角θ |
第一次 | 30mm | 61.5mm | 25.9° |
第二次 | 30mm | 61.2mm | 26.1° |
第三次 | 30mm | 60.9mm | 26.2° |
平均值 | 30mm | 61.3mm | 26.1° |
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510330842.8A CN104961749B (zh) | 2015-06-15 | 2015-06-15 | 一种头孢呋辛钠的新型工业结晶方法及其制剂 |
US15/306,084 US20170158711A1 (en) | 2015-06-15 | 2015-11-27 | Novel industrial crystallization method of cefuroxime sodium and preparation thereof |
PCT/CN2015/095810 WO2016201905A1 (zh) | 2015-06-15 | 2015-11-27 | 一种头孢呋辛钠的新型工业结晶方法及其制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510330842.8A CN104961749B (zh) | 2015-06-15 | 2015-06-15 | 一种头孢呋辛钠的新型工业结晶方法及其制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104961749A true CN104961749A (zh) | 2015-10-07 |
CN104961749B CN104961749B (zh) | 2016-01-13 |
Family
ID=54215871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510330842.8A Active CN104961749B (zh) | 2015-06-15 | 2015-06-15 | 一种头孢呋辛钠的新型工业结晶方法及其制剂 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20170158711A1 (zh) |
CN (1) | CN104961749B (zh) |
WO (1) | WO2016201905A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106279209A (zh) * | 2016-08-24 | 2017-01-04 | 南昌立健药业有限公司 | 一种注射用头孢呋辛钠的制备工艺 |
CN107383065A (zh) * | 2017-07-14 | 2017-11-24 | 浙江永宁药业股份有限公司 | 一种头孢替安盐酸盐晶体化合物及其制备方法 |
CN113788843A (zh) * | 2021-09-30 | 2021-12-14 | 海南海灵化学制药有限公司 | 一种注射用头孢呋辛钠的制备工艺 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115389653B (zh) * | 2022-08-01 | 2023-09-12 | 北京悦康科创医药科技股份有限公司 | 一种头孢呋辛钠中基因毒性杂质的检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581166A (en) * | 1983-05-19 | 1986-04-08 | Fried. Krupp Gesellschaft Mit Beschrankter Haftung | Method for isolating and purifying antibiotics |
CN101054386A (zh) * | 2006-11-12 | 2007-10-17 | 西南合成制药股份有限公司 | 头孢呋辛钠的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW293010B (en) * | 1994-04-20 | 1996-12-11 | Hui-Po Wang | Method for preparing cephalosporin derivatives |
AT411996B (de) * | 2000-09-11 | 2004-08-26 | Sandoz Ag | Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes |
-
2015
- 2015-06-15 CN CN201510330842.8A patent/CN104961749B/zh active Active
- 2015-11-27 US US15/306,084 patent/US20170158711A1/en not_active Abandoned
- 2015-11-27 WO PCT/CN2015/095810 patent/WO2016201905A1/zh active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581166A (en) * | 1983-05-19 | 1986-04-08 | Fried. Krupp Gesellschaft Mit Beschrankter Haftung | Method for isolating and purifying antibiotics |
CN101054386A (zh) * | 2006-11-12 | 2007-10-17 | 西南合成制药股份有限公司 | 头孢呋辛钠的合成方法 |
Non-Patent Citations (2)
Title |
---|
BIENKOWSKI, PAUL R.等: "Evaluation of separation and purification processes in the antibiotic industry", 《APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY》, vol. 18, 31 December 1988 (1988-12-31), pages 261 - 273, XP035176956, DOI: doi:10.1007/BF02930830 * |
ERNESTO REVERCHON等: "Supercritical antisolvent precipitation of Cephalosporins", 《POWDER TECHNOLOGY》, vol. 164, no. 3, 31 December 2006 (2006-12-31), pages 139 - 146 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106279209A (zh) * | 2016-08-24 | 2017-01-04 | 南昌立健药业有限公司 | 一种注射用头孢呋辛钠的制备工艺 |
CN107383065A (zh) * | 2017-07-14 | 2017-11-24 | 浙江永宁药业股份有限公司 | 一种头孢替安盐酸盐晶体化合物及其制备方法 |
CN113788843A (zh) * | 2021-09-30 | 2021-12-14 | 海南海灵化学制药有限公司 | 一种注射用头孢呋辛钠的制备工艺 |
CN113788843B (zh) * | 2021-09-30 | 2022-07-19 | 海南海灵化学制药有限公司 | 一种注射用头孢呋辛钠的制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
WO2016201905A1 (zh) | 2016-12-22 |
US20170158711A1 (en) | 2017-06-08 |
CN104961749B (zh) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104961749B (zh) | 一种头孢呋辛钠的新型工业结晶方法及其制剂 | |
CN103221411B (zh) | (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型 | |
US8859761B2 (en) | Refining process of Cefamandole sodium | |
CN103864819B (zh) | 一种头孢他啶化合物及其药物组合物 | |
WO2012126148A1 (zh) | 一种纯化盐酸头孢替安的新制法 | |
CN106432276A (zh) | 一种采用新型智能化结晶技术制备的头孢唑林钠化合物及其制剂 | |
CN103524532B (zh) | 一种头孢唑肟钠化合物晶型、制备方法及其药物制剂 | |
CN102643255B (zh) | 一种炎琥宁化合物 | |
CN104910186A (zh) | 一种头孢硫脒化合物 | |
CN106279208A (zh) | 一种利用流体力学原理制备的头孢噻肟钠化合物及其制剂 | |
CN103232477B (zh) | 一种盐酸头孢替安化合物、其制备方法及其药物组合物 | |
CN104926833B (zh) | 一种头孢硫脒的新型工业结晶方法及其制剂 | |
US20180111949A1 (en) | Novel industrial crystallization method of cefuroxime sodium and preparation thereof | |
CN110143957B (zh) | 头孢妥仑匹酯开环物的制备方法 | |
CN105440054B (zh) | 一种制备头孢硫脒的工艺 | |
CN109096304A (zh) | 一种3/4水头孢呋辛钠化合物 | |
CN106317080A (zh) | 一种采用耦合结晶技术制备的头孢他啶化合物及其制剂 | |
CN102391326B (zh) | 一种盐酸克林霉素棕榈酸酯化合物及其制法 | |
CN104892637B (zh) | 一种头孢孟多酯钠的新型工业结晶方法及其制剂 | |
US8871927B2 (en) | Method for purifying Ceftizoxime sodium | |
CN102746324B (zh) | 一种盐酸头孢替安的纯化方法及盐酸头孢替安无菌粉针剂 | |
CN105622635B (zh) | 一种减少过敏反应的头孢唑肟钠新晶型及其制剂 | |
CN106432279A (zh) | 一种制备治疗外科手术感染的药物头孢曲松钠晶体化合物的方法 | |
CN106432278A (zh) | 一种治疗外科手术感染的药物头孢曲松钠晶体化合物 | |
CN103304580B (zh) | 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Tao Linggang Inventor after: Hao Hongxun Inventor before: Tao Linggang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150916 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Applicant after: Hainan Lingkang Pharmaceutical Co., Ltd. Applicant after: Tianjin University Address before: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Applicant before: Hainan Lingkang Pharmaceutical Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Tao Linggang Inventor after: Hao Hongxun Inventor after: Wang Jingkang Inventor before: Tao Linggang Inventor before: Hao Hongxun |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |